Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 27, 2021

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of the Company's Derivative Instruments and the Line Items on the Unaudited Condensed Consolidated Balance Sheets

The fair values of the Company's derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of June 27, 2021, and December 31, 2020, were summarized as follows:

	Balance Sheet					Balance Sheet
	Location	June 27, 2021		December 31, 2020		Location	June 27, 2021		December 31, 2020
		(In thousands)					(In thousands)
Derivatives not designated as hedging instruments	Prepaid expenses and other current assets	$	683	$	324	Other accrued liabilities	$	250	$	2,344
Derivatives designated as hedging instruments	Prepaid expenses and other current assets		98		—	Other accrued liabilities		5		38
Total		$	781	$	324		$	255	$	2,382

Schedule of Company's Derivative Instruments on Accumulated Other Comprehensive Income and the Unaudited Condensed Consolidated Statement of Operations

The effects of the Company's derivative instruments on AOCI and the unaudited condensed consolidated statements of operations for the three and six months ended June 27, 2021 and June 28, 2020 were summarized as follows:

	Three Months Ended						Six Months Ended
	June 27, 2021			June 28, 2020			June 27, 2021			June 28, 2020
Derivatives designated as hedging instruments:
Cash flow hedges
Foreign currency forward contracts:
Gains (losses) recognized in accumulated other comprehensive income - Effective Portion	$	(308	)	$	(63	)	$	(679	)	$	922
Gains (losses) reclassified from accumulated other comprehensive income into income - Effective Portion (1):
Net revenue	$	(489	)	$	343		$	(952	)	$	1,019
Cost of revenue	$	1		$	1		$	1		$	(1	)
Research and development	$	32		$	7		$	44		$	5
Sales and marketing	$	51		$	5		$	77		$	(72	)
General and administrative	$	10		$	(1	)	$	17		$	(14	)
Derivatives not designated as hedging instruments:
Gains (losses) recognized in Other income (expense), net	$	(363	)	$	(1,128	)	$	1,053		$	650

^{(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.}